A potentially life-threatening peanut allergy has been essentially cured in nine out of 10 recipients of a new treatment which gradually escalates the amount of peanut protein the body can tolerate. Other treatments such as vaccines and antibodies are also under development, but the new oral immunotherapy is claimed to be the first to successfully allow people to tolerate such a food allergy. "We've shown fantastic results, with 80 to 90 per cent of children being able to tolerate eating peanuts regularly after treatment," says Andrew Clark of Addenbrooke's Hospital in Cambridge, UK, who co-led the team that developed the treatment.
Peanut allergy cured in children using immunotherapy New Scientist 30 January 2014
No comments:
Post a Comment